Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
In development
Guidance, NICE advice and quality standards
In development
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (1 active)
Skip to results
Filter by title or keyword
Filter
Expected publication date
Expected publication date
From date
To date
Apply date filters
Area of interest
Area of interest
COVID-19 (7)
Type
(
1 selected
)
Type
Guidance (374)
NICE advice (1)
Quality standard (9)
Guidance programme
Guidance programme
Clinical guidelines (27)
Diagnostics guidance (9)
Health technology evaluations (11)
Highly specialised technologies guidance (8)
Interventional procedures guidance (15)
Medical technologies guidance (13)
NICE guidelines (30)
Public health guidelines (1)
Technology appraisal guidance (296)
Apply filters
Showing 21 to 30 of 374
Sort by
Title
Date
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Guidance, NICE advice and quality standards in development
Title
Type
Expected publication date
Elranatamab for treating relapsed or refractory multiple myeloma after 3 therapies [ID4026]
Technology appraisal guidance
5 June 2024
Rucaparib for maintenance treatment of relapsed platinum-sensitive ovarian, fallopian tube or peritoneal cancer (Review of TA611) [ID4069]
Technology appraisal guidance
12 June 2024
Voxelotor for treating sickle cell disease [ID1403]
Technology appraisal guidance
12 June 2024
Tirzepatide for managing overweight and obesity [ID6179]
Technology appraisal guidance
19 June 2024
Tafamidis for treating transthyretin amyloidosis with cardiomyopathy [ID6327]
Technology appraisal guidance
19 June 2024
Surgical correction of hallux valgus using minimal access techniques
Interventional procedures guidance
20 June 2024
Iptacopan for treating paroxysmal nocturnal haemoglobinuria [ID6176]
Technology appraisal guidance
26 June 2024
Ganaxolone for treating seizures caused by CDKL5 deficiency disorder in people 2 years and over [ID3988]
Technology appraisal guidance
26 June 2024
Isatuximab with pomalidomide and dexamethasone for treating relapsed and refractory multiple myeloma [Review of TA658] [ID4067]
Technology appraisal guidance
26 June 2024
Selective internal radiation therapy with QuiremSpheres for treating unresectable advanced hepatocellular carcinoma (Partial review of TA688) [ID6376]
Technology appraisal guidance
3 July 2024
Previous page
1
2
Current page
3
4
5
…
38
Page
3
of
38
Next page
Results per page
10
25
50
All
Back to top